INCB059872
INCB059872 is a potent, orally active, selective and irreversible Lysine-Specific Demethylase 1 (LSD1) inhibitor. INCB059872 can be used for the research of myeloid leukemia[1].
Product Specifications
CAS Number
[1802909-49-4]
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/incb059872.html
Purity
98.06
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
OC(C1(CCC1)CN2CCC(COC)(CC2)CN[C@H]3[C@@](C4=CC=CC=C4)([H])C3)=O
Molecular Formula
C23H34N2O3
Molecular Weight
386.53
References & Citations
[1] Johnston G, et al. Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemia. Gene. 2020;752:144758.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
KDM1/LSD1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6212332-01 0.1 mL
LMO3 (LIM Domain Only Protein 3, LMO-3, Neuronal-specific Transcription Factor DAT1, Rhombotin-3, RBTN3, RBTNL2, RHOM3, MGC26081) (MaxLight 550)
Ask
View Details 
MBS6212332-02 5x 0.1 mL
LMO3 (LIM Domain Only Protein 3, LMO-3, Neuronal-specific Transcription Factor DAT1, Rhombotin-3, RBTN3, RBTNL2, RHOM3, MGC26081) (MaxLight 550)
Ask
View Details